Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Bisson

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|March 4, 2014
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitorsTai Wang, William H Bisson, Pascal Mäser, et al.
Journal of Medicinal Chemistry|August 5, 2005
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular dockingWilliam H Bisson, Leonardo Scapozza, Gerrit Westera, et al.
Carcinogenesis|June 17, 2009
Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cellsHui Nian, William H Bisson, Wan-Mohaiza Dashwood, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|May 29, 2012
Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration modelSumitra Sengupta, William H Bisson, Lijoy K Mathew, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 18, 2017
TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell DifferentiationAllison K Ehrlich, Jamie M Pennington, William H Bisson, et al.
Environmental Health Perspectives|August 13, 2016
Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research RecommendationsMark F Miller, William H Goodson, Masoud H Manjili, et al.
European Journal of Medicinal Chemistry|March 21, 2006
Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptorsLinjing Mu, Konstantin Drandarov, William H Bisson, et al.
Chemical Biology & Drug Design|November 18, 2008
Binding properties of the C-terminal domain of VIAFWilliam H Bisson, Ziming Zhang, Kate Welsh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|May 29, 2014
Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafishCory V Gerlach, Siba R Das, David C Volz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 18, 2010
Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitroAbby D Benninghoff, William H Bisson, Daniel C Koch, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|March 4, 2014
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitorsTai Wang, William H Bisson, Pascal Mäser, et al.
Journal of Medicinal Chemistry|August 5, 2005
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular dockingWilliam H Bisson, Leonardo Scapozza, Gerrit Westera, et al.
Carcinogenesis|June 17, 2009
Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cellsHui Nian, William H Bisson, Wan-Mohaiza Dashwood, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|May 29, 2012
Alternate glucocorticoid receptor ligand binding structures influence outcomes in an in vivo tissue regeneration modelSumitra Sengupta, William H Bisson, Lijoy K Mathew, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 18, 2017
TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4+ T Cell DifferentiationAllison K Ehrlich, Jamie M Pennington, William H Bisson, et al.
Environmental Health Perspectives|August 13, 2016
Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research RecommendationsMark F Miller, William H Goodson, Masoud H Manjili, et al.
European Journal of Medicinal Chemistry|March 21, 2006
Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptorsLinjing Mu, Konstantin Drandarov, William H Bisson, et al.
Chemical Biology & Drug Design|November 18, 2008
Binding properties of the C-terminal domain of VIAFWilliam H Bisson, Ziming Zhang, Kate Welsh, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|May 29, 2014
Mono-substituted isopropylated triaryl phosphate, a major component of Firemaster 550, is an AHR agonist that exhibits AHR-independent cardiotoxicity in zebrafishCory V Gerlach, Siba R Das, David C Volz, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 18, 2010
Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitroAbby D Benninghoff, William H Bisson, Daniel C Koch, et al.
Pageof 7